Nathan Hardy

2021

In 2021, Nathan Hardy earned a total compensation of $683.5K as Executive Vice President, Chief Financial Officer at Sana Biotechnology.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$170,000
Salary$413,493
Total$683,493

Hardy received $413.5K in salary, accounting for 60% of the total pay in 2021.

Hardy also received $100K in bonus and $170K in non-equity incentive plan.

Rankings

In 2021, Nathan Hardy's compensation ranked 9,971st out of 12,415 executives tracked by ExecPay. In other words, Hardy earned more than 19.7% of executives.

ClassificationRankingPercentile
All
9,971
out of 12,415
20th
Division
Manufacturing
4,413
out of 5,505
20th
Major group
Chemicals And Allied Products
1,960
out of 2,375
18th
Industry group
Drugs
1,742
out of 2,096
17th
Industry
Biological Products, Except Diagnostic Substances
378
out of 449
16th
Source: SEC filing on April 26, 2022.

Hardy's colleagues

We found two more compensation records of executives who worked with Nathan Hardy at Sana Biotechnology in 2021.

2021

Sunil Agarwal

Sana Biotechnology

Chief Medical Officer

2021

Steven Harr

Sana Biotechnology

Chief Executive Officer

News

You may also like